Feb 18, 2022
In this episode, Aaron Gerds, MD, discusses his work on clinical trials and suggestions to improve the process, the impact of COVID on these trials and his involvement in ASH Clinical News.
Aaron Gerds, MD, is assistant professor in medicine, specializing in hematology and medical oncology, at the Cleveland Clinic Taussig Cancer Institute and editor-in-chief of American Society of Hematology Clinical News.
We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Gerds can be reached on Twitter @AaronGerds.
Disclosures: Gerds reports no relevant financial disclosures. Jain reports she is a paid freelance writer for Lippincott.